ANTHONY NELSON: Open Payments
NPI 1053696344 · GLENDALE, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,234 in 52 payments from 14 companies in 2025. Trend: 2023 $916 · 2024 $1,269 · 2025 $1,234
Food & beverage: $1,234
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 9 | $291 |
| ABBVIE INC. | 18 | $257 |
| Medtronic, Inc. | 3 | $252 |
| Novo Nordisk Inc | 5 | $106 |
| PFIZER INC. | 4 | $75 |
| Boston Scientific Corporation | 2 | $47 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $38 |
| Dexcom, Inc. | 2 | $37 |
| Merck Sharp & Dohme LLC | 2 | $34 |
| Hologic Sales and Service, LLC | 1 | $24 |
Products named: VRAYLAR, AIRSUPRA, LINQ II, FARXIGA, SYMPLICITY G3, NURTEC ODT, Ozempic, JARDIANCE.
Industry payments across AZ — which companies pay providers there.
